(Circulation. 2008;118:e699-e700.)
© 2008 American Heart Association, Inc.
Images in Cardiovascular Medicine |
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn.
Reprint requests to Rowlens M. Melduni, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail melduni.rowlens{at}mayo.edu
A 77-year-old man with a history of ischemic cardiomyopathy presented with 3 days of progressively worsening dyspnea. An ECG revealed atrial fibrillation at a rate of 97 bpm. An echocardiogram showed severe left atrial enlargement, severely elevated left ventricular filling pressure, and an ejection fraction of 30%. Thyroid function studies were normal. His symptoms of dyspnea improved modestly with intravenous diuresis. A transesophageal-guided cardioversion was performed to restore atrial systole. The patient was concurrently enrolled in a research study designed to assess left atrial appendage (LAA) stunning after electric cardioversion of atrial fibrillation. After electrical cardioversion, LAA velocities were markedly reduced, and a de novo 1.14x1.17-cm mobile thrombus was detected in the LAA consistent with severe LAA stunning (Figure and online-only Data Supplement movies). The phenomenon of atrial stunning is thought to occur in most patients after cardioversion of atrial fibrillation,1,2 underscoring the importance of anticoagulation in the immediate postcardioversion period to reduce the risk of thromboembolic events.3
|
| Acknowledgment |
|---|
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Fatkin D, Kuchar DL, Thornburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994; 23: 307–316.[Abstract]
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994; 154: 1449–1457.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |